Prospective randomised controlled study comparing endonasal dacrocystorhinostomy conducted with and without potassium titanyl phosphate (KTP) laser for patients demonstrated to have nasolacrimal duct obstructio
Completed
- Conditions
- Surgery: Endonasal dacrocystorhinostomySurgeryEndonasal dacrocystorhinostomy
- Registration Number
- ISRCTN74335571
- Lead Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
100 patients who have nasolacrimal duct obstruction
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Patient acceptability of the procedure<br>2. Symptomatic reduction in epiphoria<br>3. Assessment of complication rates<br>4. Frequency of stenosis leading to recurrence of symptoms
- Secondary Outcome Measures
Name Time Method ot provided at time of registration
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie KTP laser-assisted endonasal dacrocystorhinostomy in nasolacrimal duct obstruction?
How does KTP laser use in endonasal DCR compare to standard-of-care techniques for nasolacrimal duct patency rates?
Which biomarkers predict successful outcomes in KTP laser versus non-laser endonasal DCR for nasolacrimal duct obstruction?
What adverse events are associated with KTP laser-assisted endonasal DCR and how are they managed clinically?
Are there combination therapies or alternative lasers (e.g., CO2, diode) used alongside endonasal DCR for nasolacrimal duct obstruction?